All Takeda Pharmaceutical Company articles
-
NewsScientists identify infection-halting compound that can target hosts, not viruses
Researchers at UBC’s Life Sciences Institute have identified a compound that shows early promise at halting infections from a range of coronaviruses, including all variants of SARS-CoV-2 and the common cold.
